Physician profile
Kia Mitchell
NPI 1184602583
$1,573.36
in general payments reported to CMS, 2019-2025
23 companies · $572 in 2025
The $572 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $71.19 · 2021: $250 · 2022: $70.94 · 2023: $88.65 · 2024: $236 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $305.59 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Cequr Corporation | $192.35 | 2025 | Cequr Simplicity |
| Supernus Pharmaceuticals, INC. | $170.19 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $148.90 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Cranial Technologies, INC | $107.09 | 2020-2023 | Doc Band |
| Merck Sharp & Dohme LLC | $83.88 | 2019-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $79.07 | 2019-2021 | |
| Neos Therapeutics, Lp | $58.17 | 2021 | |
| Novo Nordisk INC | $54.07 | 2025 | Wegovy |
| Adlon Therapeutics L.P. | $48.88 | 2020-2021 | |
| Ascensia Diabetes Care US INC. | $45.35 | 2023-2024 | |
| Abbvie INC. | $42.29 | 2022-2025 | |
| Pfizer INC. | $40.28 | 2025 | |
| Horizon Therapeutics Plc | $35.48 | 2022-2023 | Krystexxa |
| Inspire Medical Systems, INC. | $32.67 | 2024 | Inspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $20.00 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $17.66 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.26 | 2019 | |
| Sanofi Pasteur INC. | $17.12 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.38 | 2019 | |
| Sobi, INC | $15.71 | 2019 | |
| Phadia US INC. | $13.22 | 2019 | |
| Medline Industries Lp | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kia Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.